There is a medical crisis that almost nobody talks about.

Not because the evidence is unclear — it is extraordinarily clear.

Not because the scale is small — it affects tens of millions of people in every developed country.

Not because the consequences are minor — it kills people, puts people in hospital, and dramatically reduces the quality of life of those it doesn't kill or hospitalise.

It is called polypharmacy — the simultaneous use of multiple medications — and it is one of the most significant and most consistently ignored sources of harm in modern medicine.

The average person over 65 in the United States takes 4–5 prescription medications daily. The average nursing home resident takes 7–10. One in four Americans over 65 takes 10 or more medications simultaneously.

Each of those medications was prescribed by a doctor following the best available guidelines — most of which were written for single conditions in younger, healthier people, without accounting for the physiological changes of ageing that alter how drugs are processed and felt in the body, and without considering the other medications the person was already taking.

Each prescription made sense in isolation.

The combination — in the body of a 75-year-old with reduced kidney function, reduced liver capacity, altered drug sensitivity, depleted nutritional reserves, and a physiology that differs fundamentally from the 40-year-old clinical trial participants on whom the evidence was built — may not make sense at all.

The drug interactions, the adverse effects, the falls, the cognitive impairment, the nutritional depletions, the spiral of new prescriptions written to manage the side effects of existing ones — these are not rare complications of polypharmacy.

They are its predictable, documented, and largely preventable consequences.

And they are occurring at a scale that makes polypharmacy one of the most important medical crises of our era.

Polypharmacy is defined in most clinical literature as taking five or more medications simultaneously — though the specific number matters less than the recognition that beyond a certain threshold of medication complexity, the risks of interactions and adverse effects increase dramatically and non-linearly.

Polypharmacy is one of the defining medical paradoxes of our time.

Medicine's greatest achievement — the development of effective, evidence-based treatments for the most common conditions of modern life — has produced, through its application across multiple conditions in the same ageing body, one of its most significant unintended consequences.

The cardiologist who prescribes appropriately for atrial fibrillation. The endocrinologist who prescribes appropriately for type 2 diabetes. The rheumatologist who prescribes appropriately for arthritis. The psychiatrist who prescribes appropriately for depression. Each following evidence-based guidelines. Each making a defensible, rational clinical decision.

And the patient — taking the drugs of all four specialists, plus the over-the-counter medications they added themselves — experiencing falls, confusion, exhaustion, loss of appetite, and hospitalisation that none of the four specialists anticipated and none of the four guidelines predicted.

Because the guidelines were not written for that patient. They were written for a different patient — younger, less medicated, physiologically simpler, and managing one condition at a time.

The solution is not to abandon evidence-based medicine.

It is to apply it to the whole person — not to each condition in isolation.

It is to recognise that the evidence for adding a sixth or seventh medication to a patient already on five is almost never as strong as the evidence from the trial that tested it in patients taking one or two.

It is to take stopping medications as seriously as starting them — to make deprescribing as evidence-based, as systematic, and as celebrated an act as prescribing.

The 80-year-old who falls, fractures their hip, and dies within 12 months — having been on a benzodiazepine sleeping pill for 15 years — is as much a victim of inappropriate prescribing as any patient harmed by a drug error.

The benzodiazepine was not an error. It was prescribed thoughtfully, for a real problem, by a physician following the available evidence.

The error was never reviewing it.

Never asking: does the benefit of this drug still outweigh its risks for this specific person, at this specific age, with this specific list of other medications, at this specific stage of life?

That review — systematic, compassionate, collaborative, and grounded in the best available evidence for real patients rather than idealised trial participants — is the most important clinical act in geriatric medicine.

And it is the one most consistently not performed.

Not because doctors do not care.

Because the system does not allocate time for it. Does not train sufficiently for it. Does not measure it. Does not reward it.

Until it does — families need to know what questions to ask. What to bring to appointments. What symptoms might actually be drug effects in disguise. What conversations to initiate.

And what the evidence shows about what happens when those conversations lead to medication reduction:

The falls that don't happen.

The confusion that clears.

The energy that returns.

The quality of life that was being quietly consumed by a medication list that nobody had looked at whole for years.

The most powerful prescription in geriatric medicine is sometimes the one that is not written.

Or the one that is finally, carefully, thoughtfully stopped

www.shapeupforlife.com